Hindustan Bio Sciences Limited (BOM:532041)

Hindustan Bio Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 16, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	57	72	74	55	43	31
Market Cap Growth	-45.56%	-3.72%	36.28%	26.07%	40.67%	108.33%
Enterprise Value	83	93	100	79	64	47
Last Close Price	5.58	6.98	7.25	5.32	4.22	3.00
PE Ratio	239.24	71.05	129.03	-	-	-
PS Ratio	7.82	8.80	7.06	5.91	10.05	2.98
PB Ratio	6.65	7.91	9.24	7.30	5.50	2.36
P/TBV Ratio	6.65	7.91	9.24	7.30	5.50	2.36
P/FCF Ratio	-	264.02	-	-	-	4.08
P/OCF Ratio	-	264.02	-	-	-	4.08
EV/Sales Ratio	11.37	11.44	9.51	8.56	14.90	4.57
EV/EBITDA Ratio	-	93.20	156.74	-	-	-
EV/EBIT Ratio	-	93.38	175.41	-	-	-
EV/FCF Ratio	-18.27	343.21	-	-	-	6.27
Debt / Equity Ratio	3.04	2.77	3.18	3.29	2.75	1.43
Debt / EBITDA Ratio	97.98	25.10	40.00	-	-	-
Debt / FCF Ratio	-	92.44	-	-	-	2.47
Asset Turnover	0.22	0.24	0.32	0.30	0.13	0.23
Quick Ratio	3.11	33.30	34.57	0.33	0.13	0.44
Current Ratio	29.13	73.31	68.84	0.61	0.48	0.72
Return on Equity (ROE)	2.90%	11.78%	7.43%	-5.27%	-49.49%	-52.96%
Return on Assets (ROA)	0.43%	1.83%	1.07%	-0.68%	-9.76%	-12.99%
Return on Invested Capital (ROIC)	0.68%	2.96%	1.75%	-1.10%	-16.57%	-24.13%
Return on Capital Employed (ROCE)	0.70%	2.90%	1.70%	-1.80%	-27.10%	-46.10%
Earnings Yield	0.43%	1.41%	0.78%	-0.74%	-11.96%	-30.56%
FCF Yield	-7.96%	0.38%	-18.96%	-0.91%	-8.00%	24.49%
Buyback Yield / Dilution	-6.34%	-	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.